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Aging is characterized by a progressive decline in
multiple physiological functions (i.e., functional
aging). As animals age, they exhibit a gradual loss
in motor activity, but the underlying mechanisms
remain unclear. Here we approach this question in
C. elegans by functionally characterizing its aging
nervous system and muscles. We find that motor
neurons exhibit a progressive functional decline,
beginning in early life. Surprisingly, body-wall mus-
cles, which were previously thought to undergo
functional aging, do not manifest such a decline until
mid-late life. Notably, motor neurons first develop a
deficit in synaptic vesicle fusion followed by that in
quantal size and vesicle docking/priming, revealing
specific functional deteriorations in synaptic trans-
mission. Pharmacological stimulation of synaptic
transmission can improve motor activity in aged
animals. These results uncover a critical role for the
nervous system in age-dependent motor activity
decline in C. elegans and provide insights into how
functional aging occurs in this organism.
INTRODUCTION
Much of the current effort in aging research has been directed to
investigating the mechanisms underlying life span regulation.
This has greatly advanced our understanding of how genes and
environment control life span, particularly in various model or-
ganisms (Kenyon, 2010). Nevertheless, it should be noted that
aging is in fact characterized by gradual, progressive declines
in physiological functions of multiple tissues (i.e., functional ag-
ing), which ultimately lead to death (Wolkow, 2006). Yet, the
mechanisms underlying functional aging remain largely elusive.
Motor activity decline represents one of the most prominent
physiological declines in aging animals and humans. For
example, in the nematode C. elegans, an organism commonly
used as a model for aging research, it was reported in the392 Cell Metabolism 18, 392–402, September 3, 2013 ª2013 Elsevie1970s that aging worms exhibit a decline in motor activity and
that old worms are less active than young worms (Hosono,
1978). This phenomenon has subsequently been noted in
many other studies (Dillin et al., 2002; Glenn et al., 2004; Herndon
et al., 2002; Hosono et al., 1980; Hsu et al., 2009; Huang et al.,
2004; Johnson et al., 1988; Kenyon et al., 1993). Motor deficits
have also been observed in elderly humans, which represent
one of the main risks for injury and mortality (Faulkner et al.,
2007; MacIntosh et al., 2006). However, it remains a long-stand-
ing mystery as to what triggers the progressive decline in motor
functions in aging humans (Faulkner et al., 2007; MacIntosh
et al., 2006).
In C. elegans, the mechanisms underlying age-dependent
motor activity decline also remain unclear and somewhat contro-
versial. One model proposes that such a decline results from
muscle frailty rather than a functional deficit in the nervous sys-
tem (Herndon et al., 2002). This conclusion is based on the
finding that muscle cells undergo morphological deterioration
known as sarcopenia in old worms (Herndon et al., 2002); in
sharp contrast, the overall integrity of the nervous system
morphology is found to be well preserved even at the late stage
of worm life (Herndon et al., 2002), though these animals undergo
a decline in motor behavior and other types of behaviors (Dillin
et al., 2002; Hsu et al., 2009; Huang et al., 2004; Kauffman
et al., 2010; Murakami et al., 2005). Recent studies, however,
report that a subset of neurons in aging animals exhibit mild
morphological abnormalities such as extra neuronal branches,
and that worms in their late life (day 15) also showmorphological
deteriorations at synapses (Pan et al., 2011; Tank et al., 2011;
Toth et al., 2012). While the functional implications of these ob-
servations are unclear, it indicates that the nervous system un-
dergoes age-related changes at least at the morphological level,
suggesting a role for the nervous system in functional aging.
The controversy partly results from the lack of a systematical
evaluation of the functional status of the nervous system and
muscles throughout life span. Previous studies have largely
focused on characterizing the morphology, rather than the func-
tion, of the nervous system and muscles. However, morpholog-
ical analysis may not reliably predict the functional status of a
tissue. As such, direct functional characterizations of the aging
nervous system and muscles throughout life span are needed
to interrogate their roles in age-dependent motor activity loss.r Inc.
Figure 1. Worms Undergo Progressive Decay in Motor Activity
throughout Life Span
(A) Life span curve (Kaplan-Meier test) of N2 worms. Mean life span is 20.2 ±
0.4 (SEM) days. n = 156/173.
(B) Progressive decay in the speed of spontaneous locomotion behavior in
aging N2 worms. Worms displayed a progressive decline in locomotion speed
beginning in early life. This can be best fit by first-order exponential decay.
Error bars represent SD.
See also Figure S1.
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Functional Aging in the C. elegans Nervous SystemOne challenge, however, lies in the relative difficulty in assessing
the functional status of these tissues in C. elegans. Worm neu-
rons and muscles are relatively fragile and small compared to
those in insects and mammals (Kang et al., 2010; Waterston,
1988). This poses a technical and logistical challenge to large
scales of functional analysis throughout life span, particularly
to those involving electrophysiological recording, one of the
most frequently used approaches in neurophysiology.
In the current study, we performed a functional analysis of the
aging nervous system and muscles in C. elegans throughout life
span by patch-clamp recordings. We find that despite the pres-
ervation of their overall integrity in morphology, motor neurons
undergo a progressive decline in function, beginning in early
life. Surprisingly, no such functional decline is observed in
body-wall muscles in early-mid life, though these muscles func-
tionally deteriorate at mid-late age. We further demonstrated
that motor neurons first exhibit a deficit in synaptic vesicle fusion
in early life, which is followed by a defect in quantal size and syn-
aptic vesicle docking/priming at later ages. This identifies spe-
cific functional deficits in synaptic transmission and also reveals
a sequence of events that occur in nervous system aging. Phar-
macological interventions that potentiate synaptic transmission
of the aging nervous system can improve motor functions in
aged animals. Mutations in daf-2 that extend life span reduce
the rate of decline in motor activity and in the function of the mo-
tor nervous system. These observations unveil a critical role of
nervous system aging, suggesting that age-dependent motor
activity decay may primarily result from a progressive functional
decline in the nervous system at least during the early-mid phase
of animal life. Our studies provide insights into how functional tis-
sue aging may occur in a popular genetic model organism, and
how pharmacological and genetic interventionsmay help reduce
the rate of such functional aging.
RESULTS
Aging Worms Gradually Lose Motor Activity, Beginning
in Early Life
The N2 wild-type strain has a mean adult life span of approxi-
mately 3 weeks (20–21 days) in our hands (Figure 1A). ForCell Mesimplicity, we artificially divided their adult life span into three
phases: early life (week 1; day 1–7 adulthood), mid life (week 2;
day 8–14), and late life (after week 2; day 15–). As a first step,
we confirmed previous observations that as worms age they
gradually develop a deficit in motor activity (Dillin et al., 2002;
Glenn et al., 2004; Herndon et al., 2002; Hosono, 1978; Hosono
et al., 1980; Hsu et al., 2009; Huang et al., 2004; Johnson et al.,
1988). We employed an automated worm-tracking system
(worm tracker) to record and quantify locomotion behavior in
real time (Feng et al., 2006; Hsu et al., 2009; Li et al., 2006).
Consistent with previous reports, we found that though worms
display a slight increase in locomotion speed between day 1
and 3, they subsequently develop a gradual loss in locomotion
speed, beginning at day 5 (Figure 1B).
Aging Worms Exhibit a Progressive Decline in the
Function of the Motor Nervous System, Beginning
in Early Life
The question arises as to what mechanisms may underlie this
progressive decay in locomotion activity in aging worms. One
prominent model is that the observed decay may result from
muscle defects, as muscle cells undergo morphological deterio-
ration in old worms; yet, the overall integrity of the nervous sys-
tem morphology is well preserved even at the very late stage of
worm life (Herndon et al., 2002). However, this view cannot
explain the fact that wild-type worms exhibit a reduction inmotor
activity beginning as early as day 5 when there is no sign of
morphological deterioration in muscle sarcomeres (Glenn
et al., 2004; Herndon et al., 2002) (Figure 1B). Not until mid life
can a significant change in muscle morphology be detected
(Glenn et al., 2004; Herndon et al., 2002). Thus, morphological
deterioration in muscle cells alone cannot account for the
observed motor activity decay in aging worms.
Considering that it is the function, rather than the morpholog-
ical features, of a tissue that ultimately determines its role in a
behavior or physiological output, we reasoned that a functional
deficit in muscle cells and/or the nervous system may underlie
the observed decay in locomotion activity in aging worms partic-
ularly in their early life. However, no functional characterization of
the motor nervous system or body-wall muscles has been per-
formed on aging worms. Therefore, we decided to use electro-
physiological approaches to record the activity of the motor
nervous system and body-wall muscles in aging worms every
other day throughout their life span.
We focused on neuromuscular junctions (NMJs) in the ventral
nerve cord. NMJs are specialized synaptic structures formed by
motor neurons and muscles. NMJs in the ventral nerve cord are
mainly derived from the ventral cord motor neurons and body-
wall muscle cells, the activity of which drives locomotion
behavior in worms (Chalfie et al., 1985; White et al., 1986). Pre-
synaptic motor neurons spontaneously release neurotransmit-
ters that open muscle receptor channels at NMJs to elicit post-
synaptic currents (PSCs). Such PSCs can be recorded by
patching muscle cells under voltage clamp. The frequency of
spontaneous PSCs at NMJs measures the frequency of sponta-
neous neurotransmitter release frompresynapticmotor neurons,
which largely reflects the spontaneous activity of the motor ner-
vous system in the worm body (Madison et al., 2005; Richmond
and Jorgensen, 1999). In humans, the frequency of motor unittabolism 18, 392–402, September 3, 2013 ª2013 Elsevier Inc. 393
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Figure 2. Motor Neurons, but Not Body-Wall Muscle Receptors, Exhibit a Progressive Functional Decline in Wild-Type Worms throughout
Life Span
(A) Sample traces of spontaneous PSCs recorded from the ventral cord NMJ of aging wild-type worms. Membrane voltage was clamped at 60 mV during
recording.
(B) Bar graph of the frequency of spontaneous PSCs recorded from aging worms throughout life span. *p < 0.01; **p < 0.0001 (ANOVA with Dunnett test).
(C) Bar graph of the amplitude of spontaneous PSCs recorded from aging worms throughout life span. *p < 0.005 (ANOVA with Dunnett test).
(D) Sample traces of body-wall muscle currents evoked by ACh (100 mM) in aging worms.
(E) Bar graph of ACh-evoked currents in body-wall muscle cells of aging worms. **p < 0.0001 (ANOVA with Dunnett test).
(F) Sample traces of body-wall muscle currents evoked by GABA (100 mM) in aging worms.
(G) Bar graph of GABA-evoked currents in body-wall muscle cells of aging worms. *p < 0.005 (ANOVA with Dunnett test).
(H) Sample traces of body-wall muscle current evoked by levamisole (100 mM) in aging worms.
(I) Bar graph of levamisole-evoked currents in body-wall muscle cells of aging worms. *p < 0.05 (ANOVA with Dunnett test).
Sample sizes (n numbers) are embedded in the bars of each graph. All error bars represent SEM.
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Functional Aging in the C. elegans Nervous Systemfirings also correlates with the activity of the motor nervous sys-
tem (MacIntosh et al., 2006).
We recorded spontaneous PSCs at NMJs throughout life
span. We found that the frequency of spontaneous PSCs at
NMJs began to decline at day 5 and continued until day 17,
the last day of recording (Figures 2A and 2B). Interestingly, the
trend of this progressive decline in the frequency of spontaneous
PSCs paralleled that of progressive decay in locomotion activity
(Figure 1B). Between days 1 and 3, there was a slight increase in
the frequency of spontaneous PSCs, which is also consistent
with behavioral data (Figure 1B and data not shown). These re-
sults demonstrate that the motor nervous system undergoes a
progressive decline in function during aging, suggesting that
this functional decline (i.e., nervous system aging) contributes
to the observed progressive decay in locomotion activity in aging
worms.394 Cell Metabolism 18, 392–402, September 3, 2013 ª2013 ElsevieBody-Wall Muscle Receptors Are Functional
in Early-Mid Life
Do body-wall muscles also exhibit a similar functional decline in
aging worms? To address this question, as a first step we
analyzed the amplitude of spontaneous PSCs at NMJs. Unlike
the frequency of spontaneous PSCs, the amplitude of these
PSCs is affected by the function of both muscle receptors and
motor neurons (Madison et al., 2005; Richmond and Jorgensen,
1999). Surprisingly, the amplitude of spontaneous PSCs did not
display a significant change until mid life (day 11) (Figure 2C),
suggesting that there is no significant decline in the function of
body-wall muscle receptors in early-mid life (until day 11).
To provide additional evidence, we directly recorded the activ-
ity of muscle receptor channels every other day in aging worms
by applying their ligand toward the recorded muscle cell. Two
major types of muscle receptor channels are expressed inr Inc.
Cell Metabolism
Functional Aging in the C. elegans Nervous Systembody-wall muscles that act to drive muscle contraction and
relaxation: the excitatory nicotinic acetylcholine receptors
(nAChRs) and inhibitory GABA receptors (Richmond and Jorgen-
sen, 1999). Much to our surprise, the amplitude of ACh- and
GABA-evoked muscle currents exhibited a progressive increase
rather than a decrease in aging worms, peaking at day 9 (Figures
2D–2G). Though the amplitude of both types of currents began to
decline at day 11, it remained higher or comparable to that re-
corded at day 3 (Figures 3D–3G), indicating a lack of a deficit
in muscle receptor functions even in old worms. A similar phe-
nomenon was also observed with muscle currents evoked by
the nAChR agonist levamisole (Figures 2H and 2I). Though unex-
pected, the increase in the amplitude of ACh-, GABA-, and
levamisole-evoked muscle currents during days 3–9 might sim-
ply reflect a compensatory effect in body-wall muscle cells in
response to a reduction in synaptic input from their presynaptic
motor neurons (i.e., presynaptic neurotransmitter release) in ag-
ing worms. A related phenomenon, though under a different
physiological context, has also been reported in other organ-
isms, such as Drosophila (Davis and Goodman, 1998). These
results provide additional evidence that muscle receptors are
functional in early-mid life.
It should be noted that the observed increase in the amplitude
of ligand-evoked muscle receptor currents between day 3 and
day 9 does not necessarily indicate an increase in the amount
of postsynaptic muscle receptors present at NMJs. This is
because the amplitude of PSCs remained relatively stable dur-
ing this time window (Figure 2C). While the amplitude of PSCs
correlates with the amount of functional muscle receptors pre-
sent at synaptic (NMJ) sites under certain circumstances, the
amplitude of ligand-evoked muscle currents does not. Instead,
the latter largely reflects the overall amount of functional muscle
receptors in the entire plasma membrane of muscle cells,
including those localized at synaptic (NMJ) as well as nonsynap-
tic (non-NMJ) sites. Thus, the observed increase in the ampli-
tude of ligand-evoked muscle currents during early-mid life
(days 3–9) likely arose from an accumulation of more functional
muscle receptors at nonsynaptic (non-NMJ) sites of the plasma
membrane of muscle cells. As the amplitude of PSCs is affected
by both motor neurons andmuscles, we are unable to determine
whether the slight decrease in this parameter in mid-late life (day
11 and beyond) resulted from a deficit from neurons or muscles.
Nevertheless, our results provide strong evidence that muscle
receptors are functional at least up to mid age, suggesting
that body-wall muscles do not play a major role in motor activity
decay in aging worms at least during their early-mid life.
Mutations in daf-2 that Extend Life Span Reduce the
Rate of Functional Decline in the Motor Nervous System
Insulin/IGF-1-like signaling represents the best characterized
genetic pathway for life span regulation. Mutant worms deficient
in the insulin/IGF-1-like receptor genedaf-2arenot only long lived
but also appear healthier than wild-type worms at the same age
(Kenyon et al., 1993). Indeed, as previously reported (Hsu et al.,
2009; Kenyon et al., 1993), daf-2 worms exhibited a reduced
rate of decay in motor activity throughout life span in comparison
to wild-type (Figures 3J and 3L and see Figure S1 online).
The observation that daf-2 mutations reduced the rate of mo-
tor activity decay in aging worms raises the question as to whatCell Mephysiological mechanisms may contribute to this healthspan-
extending effect mediated by daf-2. To address this question,
we recorded the NMJs of aging daf-2 worms throughout their
life span by patch clamping. Both daf-2(e1370) and daf-
2(e1368) animals were examined every 4 days until day 27 and
day 23, respectively (Figure 3 and Figure S2). As was the case
with wild-type worms, the frequency of spontaneous PSCs in
both daf-2mutants exhibited a progressive decline with age (Fig-
ures 3A and 3B; Figures S2A and S2B); however, the rate of this
decline was much slower in daf-2 worms than that in wild-type
worms (Figures 3K and 3L). In contrast, no significant decline
in the amplitude of spontaneous PSCs was observed in daf-
2(e1370) or daf-2(e1368) aging worms up to day 27 (Figure 3C
and Figure S2C), indicative of a lack of functional deficits in mus-
cle receptors of these worms up to this age. A similar phenome-
non was also found with ACh-, GABA-, and levamisole-evoked
muscle currents in these worms (Figures 3D–3I; Figures S2D–
S2I). These results provide further evidence that muscle recep-
tors do not undergo age-dependent functional decline spanning
early-to-mid life, and suggest that daf-2 mutations may reduce
the rate of motor activity decay in aging animals primarily by
slowing down the rate of functional decline in the nervous
system.
No Significant Deficit Is Detected in the Contraction
of Body-Wall Muscles in Early-Mid Life
It might be argued that, though muscle receptors are clearly
functional in aging worms at least in their early-mid life, muscle
cells might nevertheless possess a deficit in initiating contraction
in response to activation of muscle receptors. To address this
question, we challenged worms at different ages with varying
concentrations of levamisole. Levamisole is a potent nAChR
agonist commonly used to induce contraction of body-wall mus-
cles in worms (Lackner et al., 1999); as a result, the worm body
shortens progressively. We monitored the contraction of the
worm body in response to levamisole treatment in real time using
our automated worm-tracking system (Feng et al., 2006; Hsu
et al., 2009; Li et al., 2006). In doing so, we were able to quantify
both the rate and the extent of body contraction in response to
activation of muscle receptors.
We focused on day 3, 9, and 15worms, with each representing
early, mid, and late life, respectively. We found that day 9 worms
did not display a significant deficit in the rate or extent of body
contraction induced by the muscle agonist levamisole when
compared to day 3 worms (Figure 4). In fact, day 9 worms
showed a significant increase in the extent of body contraction
triggered by levamisole at high concentrations (Figures 4A, 4B,
and 4E). Nevertheless, the rate of body contraction was reduced
in day 15 worms (Figures 4A, 4C, and 4D). It should be empha-
sized that these results are remarkably in line with our electro-
physiological data that also revealed an increase in the
amplitude of muscle receptor currents in early-mid life (Figures
2D–2I). These observations suggest that though worms devel-
oped a functional deficit in body-wall muscles in mid-late life
(day 15), there seemed to be no significant decline in the function
of body-wall muscles at the early-mid phase of life, a period dur-
ing which worms already exhibited a substantial decay in loco-
motion activity (Figure 1B). Taken together, though motor defi-
cits observed in worms in their mid-late life may be contributedtabolism 18, 392–402, September 3, 2013 ª2013 Elsevier Inc. 395
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Figure 3. daf-2(e1370) Mutation Reduces the Rate of Functional Decline in the Motor Nervous System of Aging Worms
(A) Sample traces of spontaneous PSCs recorded from the ventral cord NMJ of aging daf-2(e1370) worms. Membrane voltage was clamped at 60 mV during
recording. See Figure S2 for the recording data of daf-2(e1368) worms.
(B)Bargraphof the frequencyof spontaneousPSCsrecorded fromagingdaf-2(e1370)worms throughout life span. *p<0.05; **p<0.0005 (ANOVAwithDunnett test).
(C) Bar graph of the amplitude of spontaneous PSCs recorded from aging worms throughout life span. Error bars represent SEM.
(D) Sample traces of body-wall muscle currents evoked by ACh (100 mM) in aging worms.
(E) Bar graph of ACh-evoked currents in body-wall muscle cells of aging worms. Error bars represent SEM.
(F) Sample traces of body-wall muscle currents evoked by GABA (100 mM) in aging worms.
(G) Bar graph of GABA-evoked currents in body-wall muscle cells of aging worms. Error bars represent SEM.
(H) Sample traces of body-wall muscle currents evoked by levamisole (100 mM) in aging worms.
(I) Bar graph of levamisole-evoked currents in body-wall muscle cells of aging worms. Error bars represent SEM.
(J) The rate of progressive decay in locomotion speed is greatly reduced in aging daf-2(e1370) and daf-2(e1368) worms. The relative locomotion speed of wild-
type (N2) and daf-2mutants is plotted as a function of age. The plots can be best fitted by first-order exponential decay, and the rate of decay in each strain was
calculated and shown in (L). Error bars represent SD.
(K) The rate of progressive decay in the frequency of spontaneous PSCs at NMJs is greatly reduced in aging daf-2(e1370) and daf-2(e1368) worms. The relative
frequency of spontaneous PSCs of wild-type (N2) and daf-2mutants is plotted as a function of age. The plots can be best fitted by first-order exponential decay,
and the rate of decay in each strain was calculated and shown in (L). Error bars represent SD.
(L) Table summarizing data in (J) and (K).
Sample sizes (n numbers) are embedded in the bars of each graph. See also Figure S2.
Cell Metabolism
Functional Aging in the C. elegans Nervous Systemby functional defects in both the nervous system and body-wall
muscles, our studies suggest that at the early-mid stage of life,
progressive motor activity decay may primarily result from a pro-
gressive functional decline in the nervous system.
Motor Neurons First Develop a Deficit in Synaptic
Vesicle Fusion Followed by that in Quantal Size and
Synaptic Vesicle Docking/Priming
Having demonstrated that motor neurons, rather than body-wall
muscles, develop a deficit in early life, we next sought to inves-
tigate the underlyingmechanisms. The finding that the frequency
of spontaneous PSCs decreases with age unveils a functional396 Cell Metabolism 18, 392–402, September 3, 2013 ª2013 Elseviedeficit in synaptic release from motor neurons in aged animals.
However, this observation does not provide insights into how
synaptic release in motor neurons becomes compromised dur-
ing aging. Synaptic release from neurons (exocytosis) is a multi-
step process, including but not limited to neurotransmitter
uploading to synaptic vesicles, vesicle docking/priming, and
vesicle fusion (Figure 5A) (Su¨dhof and Rizo, 2011). A deficit in
any of these steps would lead to a reduction in synaptic release.
To ascertain at which step synaptic release is first com-
promised in aging motor neurons in early life, we performed
additional tests. We first recorded evoked PSCs at NMJs by
stimulating the ventral nerve cord with an electrode. This assayr Inc.
A B C
D E
Figure 4. Quantification of the Rate and Extent of Body Contraction in Response to Activation of Muscle Receptors in Aging Worms
(A) Time course of body contraction of day 3 worms in response to different concentrations of levamisole recorded by an automated worm-tracking system. The
worm body shortened progressively as a result of body-wall muscle contraction. The process can be best fitted by first-order exponential decay. The thick line
running through each trace is the fitting line. Each trace represents data averaged from 10 worms. Levamisole concentrations are indicated.
(B and C) Day 9 and day 15 worms, respectively.
(D) Quantification of the rate of body contraction induced by levamisole. As shown in (A)–(C), the process can be best fitted by first-order exponential decay, and
the rate of contraction can be described by the equation DL / Dt =k * L, where L denotes the body length of the animal at a given time, t denotes time, and k is a
constant. The kinetic constant k is thus used to quantify the rate of body contraction.
(E) Quantification of the extent of body contraction induced by different concentrations of levamisole. The total body contraction during the incubation time was
quantified. Quantification of day 3 and day 9 worms treated with 500 mM of levamisole was based on the first 5 min of data, as these worms reached maximal
contraction usually within the first 5 min. Error bars represent SEM. *p < 0.01 (t test). Sample sizes (n numbers) are embedded in the bars of the graph.
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Functional Aging in the C. elegans Nervous Systemallows one to interrogate how robustly presynaptic neurons
release neurotransmitters in response to nerve impulses (Rich-
mond et al., 1999). As was the case with spontaneous PSCs,
evoked PSCs also exhibited a progressive decline, beginning
at day 5 in early life (Figures 5B and 5C). This provides further ev-
idence that synaptic transmission at NMJs develops a deficit in
early life.
Because postsynaptic muscle receptors remain functionally
normal at this early age, the deficit detected in evoked PSCs
apparently arose from a reduction in synaptic release from pre-
synaptic motor neurons. In other words, some step(s) in synaptic
release from motor neurons must be compromised in early life.
To identify such a step, we first examined quantal size. Synaptic
release is quantal in nature (Del Castillo and Katz, 1954). Quantal
size can be represented by the postsynaptic response to the
neurotransmitter released by a single synaptic vesicle from the
presynaptic neuron (Del Castillo and Katz, 1954). This parameter
is affected by both the amount of neurotransmitter released from
synaptic vesicles and the function of postsynapticmuscle recep-
tors present at NMJs. This parameter would correlate with the
average amount of neurotransmitters uploaded to individual syn-
aptic vesicles in presynaptic neurons, providing that postsyn-Cell Meaptic receptors remain functionally normal. As the function of
postsynaptic muscle receptors remained relatively stable at
this age (at least up to day 9), a decrease in this parameter in
early life would suggest a deficit in the amount of neurotransmit-
ters uploaded to synaptic vesicles. If so, such a deficit would
contribute to the observed reduction in evoked PSCs. However,
we detected no significant deficit in quantal size until mid life (day
11 and beyond) (Figure 5D). This coincides with the onset of the
observed deficit in the amplitude of spontaneous PSCs (Fig-
ure 2C). A lack of a deficit in quantal size in early life, therefore,
indicates that another step (e.g., vesicle docking/priming and
vesicle fusion) in synaptic exocytosis must be compromised at
this stage of life.
To distinguish whether synaptic vesicle docking/priming or
fusion becomes defective in early life, we quantified the
amount of synaptic vesicles docked/primed at nerve terminals.
To do so, we measured the size of the readily releasable pool
(RRP) by recording PSCs at NMJs in response to hypertonic
solutions (sucrose), a parameter that is commonly used to
represent the amount of synaptic vesicles docked/primed at
nerve terminals (Su¨dhof and Rizo, 2011). Surprisingly, the
RRP size remained relatively stable throughout the early-to-midtabolism 18, 392–402, September 3, 2013 ª2013 Elsevier Inc. 397
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B Figure 5. Motor Neurons First Develop a
Deficit in Synaptic Vesicle Fusion Followed
by that in Quantal Size and Synaptic Vesicle
Docking/Priming
(A) A simplified view of synaptic exocytosis. Circles
in the neuron denote synaptic vesicles, while ovals
in the muscle represent postsynaptic receptors.
Dots in red within synaptic vesicles denote neu-
rotransmitters. The thick line in green depicts the
active zone at the presynaptic terminal.
(B) Sample traces of evoked PSCs recorded from
the ventral cord NMJ of aging wild-type worms.
(C) Bar graph summarizing the amplitude of
evoked PSCs throughout life span. *p < 0.01; **p <
0.0001 (ANOVA with Dunnett test).
(D) Quantal size. *p < 0.005 (ANOVA with Dunnett
test).
(E) Sample traces of hypertonic sucrose solution-
evoked PSCs in aging wild-type worms.
(F) The size of readily releasable pool represented
by the number of vesicles released by perfusion of
hypertonic sucrose solution. *p < 0.01 (ANOVA
with Dunnett test).
(G) The relative release probability. The same ani-
mal was recorded for hypertonic solution-trig-
gered PSCs followed by evoked PSCs. Prior to
recording evoked PSCs, a 3 min recovery was
allowed. We have done control experiments
showing that such an interval was sufficient to
permit a full recovery. The relative release proba-
bility was estimated by dividing the total number of
quantum released by hypertonic solution with that
measured in evoked PSCs. *p < 0.03; **p < 0.001
(ANOVA with Dunnett test).
Sample sizes (n numbers) are embedded in the
bars of each graph. All error bars represent SEM.
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Functional Aging in the C. elegans Nervous Systemlife of the animal, a time window during which motor neurons
already manifested a deficit in synaptic release (Figures 5E
and 5F). Apparently, though synaptic vesicles contain a normal
amount of neurotransmitters and can efficiently dock and prime
in early life, they become less efficient in fusing with motor
neuron terminals. Thus, the events upstream of synaptic
vesicle fusion (e.g., neurotransmitter uploading and vesicle
docking/priming) do not appear to be defective in early life.
This identifies synaptic vesicle fusion as an early event in ner-
vous system aging.
It should be noted that though RRP and quantal size did not
exhibit a deficit in early life, these two parameters did deterio-
rate at later ages. Specifically, quantal size began to decrease
at day 11 followed by RRP at day 15 (Figures 5D–5F). Thus,
vesicle docking/priming (represented by the size of RRP) ap-
pears to develop a deficit in late life. Nevertheless, as quantal
size is not just affected by the amount of neurotransmitter
released from synaptic vesicles (the function of postsynaptic
muscle receptors also contributes), we are unable to determine
whether neurotransmitter uploading becomes defective beyond
early life.
We further directly quantified the relative release probability of
synaptic vesicles in motor neurons by measuring both evoked
PSCs and RRP in the same animal. Given that this assay is a
lot more technically challenging, we focused on day 3, 9, and398 Cell Metabolism 18, 392–402, September 3, 2013 ª2013 Elsevie15 worms. Indeed, the relative release probability gradually
decreased with age (Figure 5G). Taken together, our results
demonstrate that motor neurons first develop a deficit in synap-
tic vesicle fusion in early life, which is followed by a defect in
quantal size and vesicle docking/priming at later ages. This iden-
tifies specific functional deficits in synaptic transmission and
also reveals a sequence of events that occur in nervous system
aging.
Effects of daf-2 Mutation on Synaptic Transmission in
Aging Motor Neurons
We then characterized how insulin/IGF-1-like signaling affects
the specific steps of synaptic transmission in aging motor neu-
rons. Similar to that observed with spontaneous PSCs, daf-2
mutant worms showed a gradual decline in the amplitude of
evoked PSCs (Figures 6A and 6B); however, the rate of the
decline was much slower than that found in wild-type worms
(Figure 6C). As was the case with wild-type, both the quantal
size and RRP size remained relatively stable in daf-2 worms up
to day 27 (Figures 6D and 6E and Figure S3). Similarly, the rela-
tive release probability of synaptic vesicles also gradually
decreased with age but at a lower rate than that in wild-type
worms (Figure 6F). Thus, a reduction in insulin/IGF-1-like
signaling slows down the rate of the functional decline in synap-
tic transmission.r Inc.
Figure 6. Effects of daf-2 Mutation on Syn-
aptic Transmission in Aging Motor Neurons
(A) Sample traces of evoked PSCs recorded from
the ventral cord NMJ of aging daf-2(e1370)
worms.
(B) Bar graph summarizing the amplitude of
evoked PSCs throughout the life span of daf-
2(e1370) worms. *p < 0.01; **p < 0.0001 (ANOVA
with Dunnett test). Error bars represent SEM.
(C) The rate of progressive decay in evoked PSCs
is reduced in aging daf-2(e1370) worms. The
relative amplitude of evoked PSCs of wild-type
(N2) and daf-2 mutant worms is plotted as a
function of age. The plots can be best fitted by
first-order exponential decay, and the rate of
decay was calculated and shown. Error bars
represent SD.
(D) Sample traces of hypertonic sucrose solution-
evoked PSCs in aging daf-2(e1370) worms.
(E) The size of readily releasable pool represented
by the number of vesicles released by perfusion of
hypertonic sucrose solutions in aging daf-2(e1370)
worms. *p < 0.02 (ANOVA with Dunnett test). Error
bars represent SEM.
(F) Normalized relative release probability. Relative
release probability in aging daf-2(e1370) worms
was calculated using the protocol described in the
legends of Figure 5G. Relative release probability
in both N2 and daf-2(e1370) worms was normal-
ized to day 3 worms. Error bars represent SEM.
Sample sizes (n numbers) are embedded in the
bars of each graph. See also Figure S3.
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in the Aging Motor Nervous System Improves Motor
Activity in Aged Worms
We then sought to provide additional evidence. We reasoned
that if the functional decline in the aging motor nervous system
leads to motor activity decay, then stimulating the activity of
the motor nervous system should stimulate motor activity in
aged worms. Previous work using behavioral assays suggests
that arecoline, a muscarinic AChR agonist, can specifically
potentiate neurotransmitter release by promoting synaptic
vesicle fusion but has no effect on the activity of muscle recep-
tors at NMJs in the ventral nerve cord (Lackner et al., 1999).
We thus wondered if arecoline can stimulate locomotion activity
in agedworms. As a first step, we examined bywhole-cell patch-
clamp recording whether arecoline can potentiate synaptic
release from motor neurons in the ventral nerve cord. We found
that arecoline treatment significantly augmented the frequency,
but not the amplitude, of spontaneous PSCs at NMJs in aged
worms (Figures 7A–7C), demonstrating that arecoline can pro-
mote the activity of motor neurons without having a direct effect
on body-wall muscle receptors. Arecoline also had no effect on
quantal size (Figure S4A). In addition, arecoline treatment did not
significantly alter the amplitude of muscle currents evoked by
ACh, GABA, or levamisole (Figures 7D and 7E; Figures S4B
and S4C), providing further evidence for the specificity of areco-
line in potentiating neuronal activities.
Lastly, we recorded evoked PSCs and found that arecoline
promoted evoked PSCs but had no effect on the size of RRP
(Figures 7F–7I). Thus, arecoline appears to potentiate the activityCell Meof the motor nervous system by specifically stimulating synaptic
vesicle fusion.
Having demonstrated that arecoline treatment can potentiate
the activity of the motor nervous system by stimulating synaptic
transmission, we then tested whether arecoline treatment can
improve locomotion activity in aged worms. We found that the
speed of locomotion in aged worms treated with arecoline was
significantly higher than that of mock-treated worms (Figure 7J;
Movie S1, Movie S2, Movie S3, and Movie S4). Arecoline treat-
ment also improved other locomotion parameters in agedworms
(Figures S4D–S4H). These results provide additional evidence
supporting a role for nervous system aging in age-dependent
motor activity decay. They also demonstrate that pharmacolog-
ical stimulation of the aging nervous system can improve motor
functions in aged animals.
DISCUSSION
Aging is characterized by a progressive functional decline in
multiple tissues (i.e., functional aging), which is associated
with an increased likelihood of death. While recent studies in
model organisms have greatly advanced our understanding of
life span regulation, much less is known about the mechanisms
underlying functional aging. To approach this question, it is
necessary to interrogate the functional status of aging tissues
throughout life span. In the current study, we performed the first
functional characterization of the aging nervous system and
muscles in C. elegans throughout life span. We uncovered a
sequence of events that occur during aging in motor neuronstabolism 18, 392–402, September 3, 2013 ª2013 Elsevier Inc. 399
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Figure 7. Pharmacological Stimulation of the Motor Nervous System Improves Locomotion Activity in Aged Worms
(A) Sample traces of spontaneous PSCs recorded from the ventral cord NMJ of aged wild-type worms (day 9 and day 15) with or without arecoline treatment.
Membrane voltage was clamped at 60 mV during recording.
(B) Frequency of spontaneous PSCs recorded from day 9 and day 15 wild-type worms with or without arecoline treatment. *p < 0.002; **p < 0.0001 (t test).
(C) Amplitude of spontaneous PSCs. The same sample as in (B) was analyzed.
(D) Sample traces of body-wall muscle currents evoked by ACh in aged wild-type worms with or without arecoline treatment.
(E) Bar graph summarizing body-wall muscle currents evoked by ACh, GABA, and levamisole in aged worms with or without arecoline treatment.
(F and G) Arecoline treatment potentiates evoked PSCs in aged worms. Day 9 and day 15 worms were tested. *p < 0.01 (t test).
(H and I) Arecoline treatment has no significant effect on the size of readily releasable pool.
(J) Arecoline treatment potentiates the speed of locomotion in aged worms. Day 9 or day 15 wormswere assayed for spontaneous locomotion behavior on plates
with or without arecoline. *p < 0.03 (t test).
Sample sizes (n numbers) are embedded in the bars of each graph. All error bars represent SEM. See also Figure S4 and Movie S1, Movie S2, Movie S3, and
Movie S4.
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Functional Aging in the C. elegans Nervous Systemand body-wall muscles. Our data show that motor neurons first
undergo a progressive decline in function, beginning in early
life. Body-wall muscles then begin to deteriorate functionally,
but not until the mid-late stage of aging. Further analysis re-
veals that motor neurons first develop a deficit in synaptic
vesicle fusion, beginning in early life, which is followed by a
defect in quantal size and vesicle docking/priming at later
ages. A similar phenomenon may occur in other types of neu-
rons in aging worms. Life span-extending mutations reduce
the rate of motor activity decay as well as the rate of functional
decline in the aging motor nervous system. Pharmacological
stimulation of the aging nervous system can improve motor
functions in aged animals. Our studies not only illustrate an
example of how functional aging may occur in a genetic model
organism but also provide insights into how genetic and phar-
macological interventions may help slow down the rate of
such functional aging.400 Cell Metabolism 18, 392–402, September 3, 2013 ª2013 ElsevieWe provided multiple lines of evidence supporting the notion
that progressive motor activity decay during aging may primarily
result from a progressive functional decline in the motor nervous
system at least during the early-to-mid phase of life. First, worms
exhibit a progressive decline in the function of motor neurons,
beginning in early life, and the trend of this decline parallels
that of motor activity decay. Second, we did not observe a
similar decline in the function of muscle receptors at this age,
and muscle contraction also appears to be largely normal up
to mid life. Instead, there seems to be an upregulation of the
overall activity of muscle receptors in early-to-mid life, probably
reflecting a compensatory effect in response to a reduction in
synaptic input from motor neurons. Third, life span-extending
mutations in daf-2 reduce the rate of motor activity decay and
the rate of functional decline in motor neurons. Lastly, we
show that pharmacological stimulation of the aging nervous sys-
tem can potentiate locomotion activity in aged worms. Theser Inc.
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Functional Aging in the C. elegans Nervous Systemobservations together suggest that functional decline in the ner-
vous system is an important mechanism that underlies progres-
sive motor activity decay in aging worms. These results also
suggest that nervous system aging may precede muscle aging
in worms. As nervous system aging can be detected in early
life, this indicates that functional tissue aging in C. elegans may
begin earlier than previously realized.
Our results do not favor the view that muscle defects underlie
motor activity decay in aging worms (Herndon et al., 2002),
which is based on morphological characterization, rather than
functional evaluation, of worm tissues during aging (Herndon
et al., 2002). Our data demonstrate that functional deficits may
develop at a time when no notable morphological deteriorations
are detected using the assays currently available.
Nevertheless, functional deficits may be accompanied by
morphological deteriorations, particularly at relatively late stages
of worm life. For example, a recent study detected a reduction in
synaptic vesicle density in some unknown head neurons in late
life (day 15) (Toth et al., 2012), a stage when motor neurons
show a severe functional deficit. Several studies reported a
growth of extra branches in some neuronal types in early-mid
life, though the functional implications of this observation remain
unclear (Pan et al., 2011; Tank et al., 2011; Toth et al., 2012). We
also identified a functional deficit in body-wall muscles in late life
(day 15), a stage when muscle morphology is severely deterio-
rated (Herndon et al., 2002). It is not known what triggers the
onset of morphological deteriorations in body-wall muscles.
One potential mechanism may involve nervous system aging—
for example, a reduction in synaptic input received by body-
wall muscles from motor neurons. In mammals, denervation
leads to muscle atrophy (MacIntosh et al., 2006).
Elderly humans also develop deficits in motor function, which
represent one of the main risks for falling that leads to injury and
mortality (Faulkner et al., 2007; MacIntosh et al., 2006). Loss of
both motor units and muscle fibers is observed during aging,
beginning in mid life (i.e., 50 years old), which is accompanied
with a decrease inmotor function; however, the mechanisms un-
derlying such a decline are not well understood (Faulkner et al.,
2007; MacIntosh et al., 2006). In particular, it remains a long-
standing mystery whether this functional decline is triggered by
nervous system aging or muscle aging (Faulkner et al., 2007;
MacIntosh et al., 2006). Our data suggest that nervous system
aging may precede muscle aging in C. elegans. Given the high
conservation of aging mechanisms between worms and other
organisms, our results raise the possibility that a similar phenom-
enon may occur in mammals.EXPERIMENTAL PROCEDURES
Quantification of Locomotion Activity, Life Span, and Body
Contraction
Locomotion behavior was assayed on NGMplates every other day throughout
life span using an automated worm-tracking system (Worm Tracker) described
previously (Feng et al., 2006; Li et al., 2006). Briefly, NGM plates were spread
with a thin layer of freshly grown OP50 bacteria 5 min prior to tracking. We per-
formed tracking at 20C under a relative humidity of40%with the lid off. The
Worm Tracker consists of a stereomicroscope (Zeiss Stemi 2000C) mounted
with a digital camera (Cohu 7800) and a digital motion system (Parker Automa-
tion) that follows worm movement. A customer-developed software package
was used to control the system. Worm images were recorded at 2 Hz forCell Me5 min, and the mean centroid speed of each worm was quantified and dis-
played in real time. To test the effect of arecoline on locomotion, the animal
was first tracked on a drug-free plate. After 4 hr of rest, the same animal
was then assayed for locomotion behavior on an arecoline-containing plate
(0.2 mM). To allow arecoline to enter the worm to elicit its effect, images
from the initial 10 min of tracking were not included for analysis.
To quantify body contraction induced by levamisole, worms were first incu-
bated in drug-free solution (140 mM NaCl, 5 mM KCl, 5 mM CaCl2, 5 mM
MgCl2, 11 mM dextrose, and 5 mM HEPES; 330 mOsm; pH adjusted to 7.2
with NaOH) and then in levamisole-containing solution for 10 min. The entire
process was recorded by an automated worm-tracking system. The vision
data were compressed and stored as a commonly used multimedia file format
(AVI), and those frames showing that part of the worm body was out of focus
were discarded. Images were thinned, and the length of the worm body was
quantified using laboratory-developed software.
Life span analysis was conducted at 20C as described previously (Kenyon
et al., 1993). In all experiments, the first day of adulthood was scored as day 1.
Each worm was scored for its viability every day. Worms that crawled off the
plate, exploded, or bagged were censored at the time of the event. All statis-
tical analyses were done using the Statistica (StatSoft, Inc.) and Statview 5.01
(SAS) software. In a parallel experiment, 240 worms of each strain were grown
on NGM plates (12 per plate), and one animal from each plate (total of 20
plates) was randomly picked (without knowing its movement capability) for
analysis of movement behavior using our automated worm-tracking system.
This behavioral experiment was repeated in Figure S1.
Electrophysiology
Whole-cell patch-clamp recordings of NMJs were performed under a 603
water immersion lens with an EPC-10 amplifier and the Patchmaster software
(HEKA), using a protocol described by Richmond et al. (Richmond and Jorgen-
sen, 1999). Voltages were clamped at 60 mV. Current data were sampled at
5 kHz. Series resistance andmembrane capacitancewere both compensated.
Sixty second recordings of spontaneous PSCs from each wormwere analyzed
for the frequency and amplitude of spontaneous PSCs using MiniAnalysis
(Synaptosoft, Inc.). Muscle receptor ligands and hypertonic sucrose solution
were applied using a pressurized perfusion system (ALA Scientific). Evoked
PSCs were triggered by a 0.5 ms pulse (25 V) using a stimulating electrode
placed in close proximity to the ventral nerve cord. Recording pipettes (4–
6 MU) were pulled from borosilicate glass and fire polished. The pipette solu-
tion contains 120mMKCl, 20mMKOH, 4mMMgCl2, 10mMHEPES, 0.25mM
CaCl2, 36 mM sucrose, 5 mM EGTA, and 4 mM Na2ATP (315 mOsm; pH
adjusted to 7.2). The bath solution contains 140 mM NaCl, 5 mM KCl, 5 mM
CaCl2, 5 mM MgCl2, 11 mM dextrose, and 5 mM HEPES (330 mOsm; pH
adjusted to 7.2). Muscle receptor ligands were diluted in bath solution to a final
concentration of 100 mM. Hypertonic solution was made by adding sucrose to
bath solution to a final concentration of 1 M. Quantal size (net charge transfer
per quantum) was estimated by analyzing miniature spontaneous PSC traces.
To estimate the RRP size, we quantified the number of vesicles (quantal con-
tent) released by 5 s application of hypertonic solution. Quantal content in
evoked PSCs was calculated in a similar manner. Basal line release was sub-
tracted. To record the effects of arecoline on NMJ activity, worms were pre-
treated with arecoline (0.2 mM) for10 min and recorded in bath solution con-
taining the same concentration of arecoline.
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